Babson Diagnostics offers BetterWay™ blood testing, which uses about one-tenth the volume of traditional draws and collects a small, pea-sized sample from the fingertip.
Published
Signal category
Products & Services
Quote
“BetterWay™ blood testing uses about one-tenth the volume of traditional draws: a small, pea-sized sample collected from the fingertip.”
— Babson Diagnostics team
Company
Babson Diagnostics
Blood testing reimagined
- Industry
- Medical and Diagnostic Laboratories
- Location
- Austin, US
- Company size
- 54 employees
BetterWay™ is blood testing reimagined—patient-friendly fingertip collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing. Babson was named 2024 Medtech Company of the Year by MD + DI, 2025 SXSW Innovation Award winner for Health & Biotech, and one of Fast Company’s 2025 Most Innovative Companies in Healthcare. For more information, please visit BetterWay.com.
Founded 2017